Biotech Values

[drbio45]

He picked up coverage at the perfect time for Roth because as the post you responded to said they need cash

Vaino terminated coverage of pluristem today after doubling the price target in january to 4 dollars. They raised 38 million dollars which means they won't have a financial overhang for three years which is great. Problem is Roth can't do a financing for three years.

take back what you said about him being a good analyst.